|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 35/00 | |
| A61P 43/00 | |||
| A61P 35/02 | |||
| C07K 14/705 | |||
| C07K 14/725 | |||
| C07K 16/28 | |||
| A61K 35/17 |
| (11) | Patento numeris | 3149044 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15729304.4 |
| Europos patento paraiškos padavimo data | 2015-06-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-04-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-10-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/033473 |
| Data | 2015-06-01 |
| (87) | Numeris | WO 2015/187528 |
| Data | 2015-12-10 |
| (30) | Numeris | Data | Šalis |
| 201462006313 P | 2014-06-02 | US |
| (72) |
KOCHENDERFER, James N., US
|
| (73) |
The U.S.A. as represented by the Secretary, Department of Health and Human Services,
Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325, MSC 7660, Bethesda, MD 20892-7660,
US
|
| (54) | CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19 |
| CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19 |